Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a publication citation for Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032) from Lancet Oncology with an Erratum. Replaced the older citation version (v3.5.0) with the updated entry (v3.5.2).SummaryDifference0.1%

- Check16 days agoChange DetectedPadua, Italy, 35128 was deleted and Padova, Italy, 35128 was added in the Locations section.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a publication citation for the CheckMate-032 study (J Clin Oncol, 2018). Deleted the erratum note for that publication (J Clin Oncol, 2019).SummaryDifference0.0%

- Check31 days agoChange DetectedNapoli, Italy, 80131 was changed to Naples, Italy, 80131 in the Locations section.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag was updated to v3.5.0 and the previous v3.4.3 tag was removed.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the study details or associated information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.